Biotech · Private company · Kingston, RI, US
MindImmune Therapeutics, Inc.
Track this companyFree. Adds MindImmune Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials1
- Exploratory Open Label Study for Development of a Method To Detect Dendritic CellsCOMPLETED · started Nov 28, 2022ClinicalTrials.gov NCT05482867 · fetched Nov 12, 2026
NIH awards1
- Targeting CD11c immune cells to alleviate cerebral amyloid angiopathy and amyloid-related imaging abnormality in patients with Alzheimer's diseaseFiscal year 2026 · $496.4KNIH RePORTER 1R43AG102103-01 · fetched Nov 12, 2026